{"title":"Intestinal Perforation in a Case of Peripheral T Cell Lymphoma after Initiation of Chemotherapy.","authors":"Raju Ponnusamy, Pinak Dasgupta, Ajay Pai","doi":"10.4166/kjg.2024.072","DOIUrl":null,"url":null,"abstract":"<p><p>Non-Hodgkin's lymphoma (NHL) is the most common type of Gastrointestinal (GI) lymphoma with known complications such as bleeding, obstruction and perforation. In this article we present a 59-year-old male patient diagnosed with Peripheral T cell Lymphoma - Not Otherwise Specified (PTCL-NOS) with GI involvement was started on chemotherapy. On day 2 post completion of first cycle of chemotherapy, patient had presented to the emergency department with sudden onset abdominal pain and distension. On evaluation, he was diagnosed with multiple perforations in the small bowel. Patient underwent exploration with primary repair of few perforations and ileal resection with double barrel ileostomy. Chemotherapy plays an important role in the management of NHL. One well-known NHL consequence, intestinal perforation, can happen at the time of initial presentation or after starting chemotherapy. Surgeons should be aware of possibility of such complications and high-risk factors for perforation. At present, there is no role for elective surgery in GI lymphoma and is mainly reserved for complications like uncontrolled bleeding, obstruction or perforation.</p>","PeriodicalId":94245,"journal":{"name":"The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi","volume":"84 2","pages":"90-94"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4166/kjg.2024.072","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Non-Hodgkin's lymphoma (NHL) is the most common type of Gastrointestinal (GI) lymphoma with known complications such as bleeding, obstruction and perforation. In this article we present a 59-year-old male patient diagnosed with Peripheral T cell Lymphoma - Not Otherwise Specified (PTCL-NOS) with GI involvement was started on chemotherapy. On day 2 post completion of first cycle of chemotherapy, patient had presented to the emergency department with sudden onset abdominal pain and distension. On evaluation, he was diagnosed with multiple perforations in the small bowel. Patient underwent exploration with primary repair of few perforations and ileal resection with double barrel ileostomy. Chemotherapy plays an important role in the management of NHL. One well-known NHL consequence, intestinal perforation, can happen at the time of initial presentation or after starting chemotherapy. Surgeons should be aware of possibility of such complications and high-risk factors for perforation. At present, there is no role for elective surgery in GI lymphoma and is mainly reserved for complications like uncontrolled bleeding, obstruction or perforation.
非霍奇金淋巴瘤(NHL)是最常见的胃肠道(GI)淋巴瘤,已知可引起出血、梗阻和穿孔等并发症。本文介绍了一名59岁的男性患者,他被诊断为外周T细胞淋巴瘤-未另作说明(PTCL-NOS)并累及消化道,患者开始接受化疗。第一周期化疗结束后第 2 天,患者因突发腹痛和腹胀到急诊科就诊。经评估,他被诊断为小肠多处穿孔。患者接受了探查术,对少数穿孔进行了初步修补,并进行了回肠切除术和双管回肠造口术。化疗在 NHL 的治疗中发挥着重要作用。肠穿孔是众所周知的 NHL 后果之一,可能发生在初次发病时或开始化疗后。外科医生应了解此类并发症的可能性以及穿孔的高危因素。目前,选择性手术在消化道淋巴瘤中并不适用,主要用于无法控制的出血、梗阻或穿孔等并发症。